GSK - one of the world's leading research-based pharmaceutical and healthcare companies - is committed to improving the quality of human life by enabling people to do more, feel better and live longer.
Business & Industry
- Pfizer and BioNTech receive first U.S. FDA Emergency Use Authorization of a COVID-19 vaccine booster
- Novartis acquires Arctos Medical, expanding optogenetics portfolio to bring gene therapies to patients with severe vision loss
- Pfizer and BioNTech announce positive topline results from pivotal trial of COVID-19 vaccine in children 5 to 11 years
- University of Oxford and Oracle Cloud System helping researchers identify COVID-19 variants faster
- Roche opens access to pathology imaging tools to improve patient care
Research & Development
- Therapy using dual immune system cells effectively controls neuroblastoma
- COVID-19 nasal vaccine candidate effective at preventing disease transmission
- How a plant virus could protect and save your lungs from metastatic cancer
- Scientific evidence to date on COVID-19 vaccine efficacy does not support boosters for general population
- NIH scientists build a cellular blueprint of multiple sclerosis lesions
- First-in-human clinical trial for a vaccine to treat opioid use disorders enrolls first patients
- No serious health effects linked to mRNA COVID-19 vaccines
Conferences & Events
- Novartis, Bayer and Boehringer Ingelheim to showcase their commitment to a reimagined pharma industry
- Scientists urge for investment now in highly potent vaccines to prevent the next pandemic
- CPhI Worldwide to return in 2021
- Reuters Events' Cell & Gene Therapy USA
- Total health: Build a better healthcare system
- Don't fall for the 'next best action' trap
- Locking down shape-shifting spike protein aids development of COVID-19 vaccine
Regulatory Affairs
- FDA authorizes software that can help identify prostate cancer
- FDA advances data, IT modernization efforts with new office of digital transformation
- ECDC and EMA highlight considerations for additional and booster doses of COVID-19 vaccines
- FDA approves first COVID-19 vaccine
- FDA approves new treatment for Pompe disease